Human genome sequencing has fundamentally changed healthcare by making it possible to understand genetic predispositions, enabling personalized treatment plans that cater to individuals' unique genetic blueprints.
The progressive drop in sequencing costs, from $10 million to $400, reflects not just technological advancements but also a shift towards accessibility in genetic healthcare for everyone.
The potential for widespread genome sequencing could revolutionize preventive health care, allowing individuals to foresee and mitigate risks associated with genetic disabilities or diseases.
As the cost of genome sequencing continues to decline, we stand on the brink of a new era in healthcare, where DNA insights will guide personalized medicine.
Collection
[
|
...
]